Qing-Hua Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Qing-Hua Liu has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Baozhong Zhu
Department of Clinical Laboratory, Second hospital of Shanxi Medical University, Taiyuan, China
1 shared publication - Bingmei Chang
Department of Biochemistry and Molecular Biology, Shanxi Medical University, Taiyuan, People’s Republic of China
1 shared publication - Bowei Wu
Department of Physiology and Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan, China
1 shared publication - Deping Wang
Key Laboratory of Regenerative Biology and Institute of Chemical Biology, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China
1 shared publication - Haixiong Wang
Shanxi Key Laboratory of Heart Failure Precision Medicine, Cardiovascular Hospital Affiliated to Shanxi Medical University, 030024 Taiyuan, Shanxi, China
1 shared publication - Ji-Min Cao
MOE Key Laboratory of Cellular Physiology, and the Department of Physiology, Shanxi Medical University, Taiyuan, China
1 shared publication
Latest Publications
- 21 December 2023
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 42 (5) , 816-827
Nerve growth factor (Ngf) gene-driven semaphorin 3a (Sema3a) expression exacerbates thoracic aortic aneurysm dissection in mice
Thoracic aortic aneurysm and dissection (TAAD) is a life-threatening disease and currently there is no pharmacological therapy. Sympathetic nerve overactivity plays an important role in the development of TAAD. Sympathetic innervation is mainly controlled by nerve growth factor (NGF, a key neural chemoattractant) and semaphoring 3A (Sema3A, a key neural chemorepellent), while the roles of these two factors in aortic sympathetic innervation and especially TAAD are unknown. We hypothesized that genetically manipulating the NGF/Sema3A ratio by the Ngf-driven Sema3a expression approach may reduce aortic sympathetic nerve innervation and mitigate TAAD progression. A mouse strain of Ngf gene-driven Sema3a expression (namely Ngf Sema3a/Sema3a mouse) was established by inserting the 2A-Sema3A expression frame to the Ngf terminating codon using CRISPR/Cas9 technology. TAAD was induced by β-aminopropionitrile monofumarate (BAPN) both in Ngf Sema3a/Sema3a mice and wild type (WT) littermates. Contrary to our expectation, the BAPN-induced TAAD was severer in Ngf Sema3a/Sema3a mice than in wild-type (WT) mice. In addition, Ngf Sema3a/Sema3a mice showed higher aortic sympathetic innervation, inflammation and extracellular matrix degradation than the WT mice after BAPN treatment. The aortic vascular smooth muscle cells isolated from Ngf Sema3a/Sema3a mice and pretreated with BAPN in vivo for two weeks showed stronger capabilities of proliferation and migration than that from the WT mice. We conclude that the strategy of Ngf-driven Sema3a expression cannot suppress but worsens the BAPN-induced TAAD. By investigating the aortic phenotype of Ngf Sema3a/Sema3a mouse strain, we unexpectedly find a path to exacerbate BAPN-induced TAAD which might be useful in future TAAD studies.
- 21 December 2023
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 42 (5) , 816-827
Nerve growth factor (Ngf) gene-driven semaphorin 3a (Sema3a) expression exacerbates thoracic aortic aneurysm dissection in mice
Thoracic aortic aneurysm and dissection (TAAD) is a life-threatening disease and currently there is no pharmacological therapy. Sympathetic nerve overactivity plays an important role in the development of TAAD. Sympathetic innervation is mainly controlled by nerve growth factor (NGF, a key neural chemoattractant) and semaphoring 3A (Sema3A, a key neural chemorepellent), while the roles of these two factors in aortic sympathetic innervation and especially TAAD are unknown. We hypothesized that genetically manipulating the NGF/Sema3A ratio by the Ngf-driven Sema3a expression approach may reduce aortic sympathetic nerve innervation and mitigate TAAD progression. A mouse strain of Ngf gene-driven Sema3a expression (namely Ngf Sema3a/Sema3a mouse) was established by inserting the 2A-Sema3A expression frame to the Ngf terminating codon using CRISPR/Cas9 technology. TAAD was induced by β-aminopropionitrile monofumarate (BAPN) both in Ngf Sema3a/Sema3a mice and wild type (WT) littermates. Contrary to our expectation, the BAPN-induced TAAD was severer in Ngf Sema3a/Sema3a mice than in wild-type (WT) mice. In addition, Ngf Sema3a/Sema3a mice showed higher aortic sympathetic innervation, inflammation and extracellular matrix degradation than the WT mice after BAPN treatment. The aortic vascular smooth muscle cells isolated from Ngf Sema3a/Sema3a mice and pretreated with BAPN in vivo for two weeks showed stronger capabilities of proliferation and migration than that from the WT mice. We conclude that the strategy of Ngf-driven Sema3a expression cannot suppress but worsens the BAPN-induced TAAD. By investigating the aortic phenotype of Ngf Sema3a/Sema3a mouse strain, we unexpectedly find a path to exacerbate BAPN-induced TAAD which might be useful in future TAAD studies.
- 22 December 2020
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 26 (44) , 5746-5754
Zacopride Exerts an Antiarrhythmic Effect by Specifically Stimulating the Cardiac Inward Rectifier Potassium Current in Rabbits: Exploration of a New Antiarrhythmic Strategy
Background: Zacopride, a potent antagonist of 5-HT3 receptors and an agonist of 5-HT4 receptors, is a gastrointestinal prokinetic agent. In a previous study, we discovered that zacopride selectively stimulated the inward rectifier potassium current (IK1) in the rat and that agonizing IK1 prevented or eliminated aconitine-induced arrhythmias in rats. Objective: Our aims were to confirm that the antiarrhythmic effects of zacopride are mediated by selectively enhancing IK1 in rabbits. Methods: The effects of zacopride on the function of the main ion channels were investigated using a whole-cell patch-clamp technique in rabbits. Effects of zacopride on cardiac arrhythmias were also explored experimentally both in vivo and in vitro. Results: Zacopride moderately enhanced cardiac IK1 but had no apparent action on voltage-gated sodium current (INa), L- type calcium current (ICa-L), sodium-calcium exchange current (INa/Ca), transient outward potassium current (Ito), or delayed rectifier potassium current (IK) in rabbits. Zacopride also had a marked antiarrhythmic effect in vivo and in vitro. We proved that the resting membrane potential (RMP) was hyperpolarized in the presence of 1 μmol/L zacopride, and the action potential duration (APD) at 90% repolarization (APD90) was shortened by zacopride (0.1-10 μmol/L) in a concentration- dependent manner. Furthermore, zacopride at 1 μmol/L significantly decreased the incidence of drug-induced early afterdepolarization (EAD) in rabbit ventricular myocytes. Conclusion: Zacopride is a selective agonist of rabbit cardiac IK1 and that IK1 enhancement exerts potential antiarrhythmic effects.
- 22 December 2020
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 26 (44) , 5746-5754
Zacopride Exerts an Antiarrhythmic Effect by Specifically Stimulating the Cardiac Inward Rectifier Potassium Current in Rabbits: Exploration of a New Antiarrhythmic Strategy
Background: Zacopride, a potent antagonist of 5-HT3 receptors and an agonist of 5-HT4 receptors, is a gastrointestinal prokinetic agent. In a previous study, we discovered that zacopride selectively stimulated the inward rectifier potassium current (IK1) in the rat and that agonizing IK1 prevented or eliminated aconitine-induced arrhythmias in rats. Objective: Our aims were to confirm that the antiarrhythmic effects of zacopride are mediated by selectively enhancing IK1 in rabbits. Methods: The effects of zacopride on the function of the main ion channels were investigated using a whole-cell patch-clamp technique in rabbits. Effects of zacopride on cardiac arrhythmias were also explored experimentally both in vivo and in vitro. Results: Zacopride moderately enhanced cardiac IK1 but had no apparent action on voltage-gated sodium current (INa), L- type calcium current (ICa-L), sodium-calcium exchange current (INa/Ca), transient outward potassium current (Ito), or delayed rectifier potassium current (IK) in rabbits. Zacopride also had a marked antiarrhythmic effect in vivo and in vitro. We proved that the resting membrane potential (RMP) was hyperpolarized in the presence of 1 μmol/L zacopride, and the action potential duration (APD) at 90% repolarization (APD90) was shortened by zacopride (0.1-10 μmol/L) in a concentration- dependent manner. Furthermore, zacopride at 1 μmol/L significantly decreased the incidence of drug-induced early afterdepolarization (EAD) in rabbit ventricular myocytes. Conclusion: Zacopride is a selective agonist of rabbit cardiac IK1 and that IK1 enhancement exerts potential antiarrhythmic effects.
- Open Access
- 11 May 2017
- Published by MedCrave Group Kft. in International Journal of Complementary and Alternative Medicine
- Vol. 7 (1) , 1-2
Taste Receptors Type 2 Would Not Mediate Bitter Tastant-Induced Relaxation of Airway Smooth Muscle
Recently, it has been found that taste receptors type 2 (TAS2R) are expressed in airway smooth muscle (ASM) cells and their activators bitter tastants inhibit ASM contraction induced by agonists. In this mini review, we summarized the progress in understanding of bitter Tastant-induced ASM relaxation. We also mentioned the inhibitory action and the underlying mechanism of bitter tastants extracted from bitter herbs. These recent findings indicate that bitter tastants would be a novel class of bronchodilators for the treatment of obstructive lung diseases such as asthma and chronic obstructive pulmonary disease (COPD). Mechanism of Bitter Tastant-Induced Relaxation Taste receptors type 2 (TAS2R) are responsible for detecting bitter sensation [1], which have recently been found to be expressed in ASM cells and which mediate inhibition on the
- 11 May 2017
- Published by MedCrave Group Kft. in International Journal of Complementary and Alternative Medicine
- Vol. 7 (1) , 1-2
Open AccessTaste Receptors Type 2 Would Not Mediate Bitter Tastant-Induced Relaxation of Airway Smooth Muscle
Recently, it has been found that taste receptors type 2 (TAS2R) are expressed in airway smooth muscle (ASM) cells and their activators bitter tastants inhibit ASM contraction induced by agonists. In this mini review, we summarized the progress in understanding of bitter Tastant-induced ASM relaxation. We also mentioned the inhibitory action and the underlying mechanism of bitter tastants extracted from bitter herbs. These recent findings indicate that bitter tastants would be a novel class of bronchodilators for the treatment of obstructive lung diseases such as asthma and chronic obstructive pulmonary disease (COPD). Mechanism of Bitter Tastant-Induced Relaxation Taste receptors type 2 (TAS2R) are responsible for detecting bitter sensation [1], which have recently been found to be expressed in ASM cells and which mediate inhibition on the